Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001545 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders
A Phase 2 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 2
- Development phase
- 91
- Enrollment target
NCT00001545 is a Phase 2 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 91 participants.
The verdict
NCT00001545, a Phase 2 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 91 participants
- Enrollment target
Study Summary
This study is designed to evaluate repetitive transcranial magnetic stimulation (rTMS) as a potential treatment for depression. In rTMS, a rapidly changing magnetic field passes through your scalp and skull and generates a small electrical pulses in your brain. rTMS at lower intensities has helped some people with depression but we do not know what the results will be in your case using higher intensities, or whether you will be randomized to 3 weeks of high frequency (20 cycles er second), low frequency (1 cycle per second), or inactive (sham)rTMS. You will be assigned to receive one of these types of rTMS over the left front art of your brain five times per week for the three weeks. Each rTMS treatment session should take between 20-30 minutes of actual stimulation, but weekly ratings, memory testing, and blood sampling may require several hours per week. We will also ask you to have brain imaging procedures to see if these will predict response to high vs. low frequency rTMS. If you are randomized to the 3 weeks of sham rTMS, you will have the opportunity to receive one of the active stimulation frequencies for an additional 3 weeks. Responders to any phase will be offered an additional month of rTMS prior to study termination and recommendations of alternative treatments.
Interventions
- DEVICE Magstim Super Rapid Magnetic Stimulator
- DEVICE Cadwell MES-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 1996-05 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001545
The ClinicalTrials.gov registry entry for NCT00001545 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magstim Super Rapid Magnetic Stimulator is the first listed.
NCT00001545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001545 about?
NCT00001545 is a clinical study titled "Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders". This study is designed to evaluate repetitive transcranial magnetic stimulation (rTMS) as a potential treatment for depression. In rTMS, a rapidly changing magnetic field passes through your scalp and skull and generates a small electrical pulses in your brain. rTMS at lower intensities has helped s...
What is the current status of trial NCT00001545?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 91 participants. The study started on 1996-05. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00001545?
The interventions under investigation include: Magstim Super Rapid Magnetic Stimulator (DEVICE), Cadwell MES-10 (DEVICE).
Who is sponsoring clinical trial NCT00001545?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.